BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1395428)

  • 1. Case report: life-threatening hypercalcaemia secondary to pancreatic tumour secreting parathyroid hormone-related protein--successful control by hepatic arterial embolization.
    Tarver DS; Birch SJ
    Clin Radiol; 1992 Sep; 46(3):204-5. PubMed ID: 1395428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone-related protein in pancreatic exocrine cancer associated with hypercalcaemia.
    Bandyopadhyay P; Baksi S; Bandyopadhyay D; Patel CU
    Int J Clin Pract; 2003 Mar; 57(2):140-2. PubMed ID: 12661799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failure.
    Abraham P; Ralston SH; Hewison M; Fraser WD; Bevan JS
    Postgrad Med J; 2002 Dec; 78(926):752-3. PubMed ID: 12509695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone-related protein mediates hypercalcemia in an exocrine pancreatic cancer.
    Tachibana I; Nakano S; Akiyama T; Ogami Y; Tabaru A; Otsuki M
    Am J Gastroenterol; 1994 Sep; 89(9):1580-1. PubMed ID: 8079945
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
    Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour.
    Mantzoros CS; Suva LJ; Moses AC; Spark R
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):373-5. PubMed ID: 9156050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
    Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
    Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcaemia in small cell lung cancer: report of a case associated with parathyroid hormone-related protein (PTHrP).
    Stuart-Harris R; Ahern V; Danks JA; Gurney H; Martin TJ
    Eur J Cancer; 1993; 29A(11):1601-4. PubMed ID: 8217368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.
    Srirajaskanthan R; McStay M; Toumpanakis C; Meyer T; Caplin ME
    Neuroendocrinology; 2009; 89(1):48-55. PubMed ID: 18679021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a malignant pancreatic endocrine tumour secreting parathyroid hormone related protein.
    Wynick D; Ratcliffe WA; Heath DA; Ball S; Barnard M; Bloom SR
    BMJ; 1990 May; 300(6735):1314-5. PubMed ID: 2164430
    [No Abstract]   [Full Text] [Related]  

  • 11. Embolization in the palliation of complications of inoperable primary pancreatic neoplasms.
    Khoursheed M; Crotch-Harvey MA; Gould DA
    Clin Radiol; 1994 Nov; 49(11):784-6. PubMed ID: 7525141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone related protein and hypercalcaemia in breast cancer.
    Bundred NJ; Ratcliffe WA; Walker RA; Coley S; Morrison JM; Ratcliffe JG
    BMJ; 1991 Dec; 303(6816):1506-9. PubMed ID: 1782489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare case of pancreatic neuroendocrine tumour presenting as paraneoplastic hypercalcaemia.
    Ferrel B; Franko J; Tee MC
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33858893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcaemia due to parathyroid hormone-related protein: long-term circulating levels may not reflect tumour activity.
    Savage MW; Fraser WD; Bodmer CW; Ginty AF; Gallagher JA; Robinson J; Williams G
    Clin Endocrinol (Oxf); 1993 Dec; 39(6):695-8; discussion 699. PubMed ID: 8287589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone related protein (PTHrP) mediated hypercalcaemia complicating enteropancreatic malignancy in multiple endocrine neoplasia type 1 (MEN 1).
    Burgess JR; Wilkinson S; Lowenthal RM
    Aust N Z J Med; 2000 Apr; 30(2):280-1. PubMed ID: 10833127
    [No Abstract]   [Full Text] [Related]  

  • 16. Humoral hypercalcaemia in renal carcinoma due to parathyroid hormone related protein.
    Sandhu DP; Munson KW; Harrop JS; Hopton MR; Ratcliffe WA
    Br J Urol; 1993 Dec; 72(6):848-50. PubMed ID: 8306145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of parathyroid hormone-related protein in tumour xenografts in nude mice presenting with hypercalcaemia.
    Miyake Y; Yamaguchi K; Honda S; Nagasaki K; Tsuchihashi T; Mori M; Kimura S; Abe K
    Br J Cancer; 1991 Feb; 63(2):252-6. PubMed ID: 1997102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid-hormone-related protein in tumours associated with hypercalcaemia.
    Heath DA; Senior PV; Varley JM; Beck F
    Lancet; 1990 Jan; 335(8681):66-9. PubMed ID: 1967417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcaemia in malignancy.
    Heath DA
    BMJ; 1989 Jun; 298(6686):1468-9. PubMed ID: 2503074
    [No Abstract]   [Full Text] [Related]  

  • 20. Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.
    Teng J; Abell S; Hicks RJ; Hofman MS; Sachithanandan N; McKelvie P; MacIsaac RJ
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):940-2. PubMed ID: 24890549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.